Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-08-059304
Filing Date
2008-10-24
Accepted
2008-10-24 17:06:43
Documents
6
Period of Report
2008-10-24

Document Format Files

Seq Description Document Type Size
1 v129677_6k.htm 6-K 29732
2 v129677_ex1-1.htm EX-1.1 70035
3 v129677_ex1-2.htm EX-1.2 150058
4 v129677_ex1-3.htm EX-1.3 116269
5 v129677_ex1-4.htm EX-1.4 152971
6 v129677_ex1-5.htm EX-1.5 114691
  Complete submission text file 0001144204-08-059304.txt   635149
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 081140663
SIC: 2834 Pharmaceutical Preparations